US 7,534,778 B2
(20S)-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
Hector F. DeLuca, Deerfield, Wis. (US); Lori A. Plum, Madison, Wis. (US); and Margaret Clagett-Dame, Madison, Wis. (US)
Assigned to Wisconsin Alumni Research Foundation, Madison, Wis. (US)
Filed on Nov. 21, 2007, as Appl. No. 11/944,150.
Application 11/011704 is a division of application No. 10/462272, filed on Jun. 16, 2003, granted, now 6,887,860.
Application 10/462272 is a division of application No. 10/078204, filed on Feb. 18, 2002, granted, now 6,627,622.
Application 11/944150 is a continuation of application No. 11/011704, filed on Dec. 14, 2004, abandoned.
Claims priority of provisional application 60/341138, filed on Dec. 13, 2001.
Prior Publication US 2008/0096851 A1, Apr. 24, 2008
Int. Cl. A61K 31/59 (2006.01)
U.S. Cl. 514—167 5 Claims
OG exemplary drawing
 
1. A method of treating renal osteodystrophy comprising administering to a patient with renal osteodystrophy an effective amount of (20S)-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol having the formula:

OG Complex Work Unit Drawing